Lisata Therapeutics, Inc. SEC filings LSTA

Lisata Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form ARS, was filed on Oct 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Oct 19, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 28, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 28, 2024 Dec 31, 2023
10-K Annual report Feb 29, 2024 Dec 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 21, 2022 Dec 31, 2021
10-K Annual report Mar 22, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Mar 5, 2020 Dec 31, 2019
10-K/A Amended annual report Mar 19, 2019 Mar 19, 2019
10-K Annual report Mar 14, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 2, 2018 Apr 2, 2018
10-K Annual report Mar 22, 2018 Dec 31, 2017
10-K Annual report Mar 17, 2017 Dec 31, 2016
10-K/A Amended annual report Apr 29, 2016 Dec 31, 2015
10-K Annual report Mar 15, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 30, 2015 Dec 31, 2014
10-K Annual report Mar 2, 2015 Dec 31, 2014
10-K Annual report Mar 13, 2014 Dec 31, 2013
10-K/A Amended annual report Mar 13, 2014 Dec 31, 2012
10-K Annual report Mar 11, 2013 Dec 31, 2012
10-K/A Amended annual report Apr 30, 2012 Dec 31, 2011
10-K Annual report Mar 20, 2012 Dec 31, 2011

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LSTA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Basking Ridge, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
320017
Former names
Caladrius Biosciences, Inc. (until Sep 15, 2022); CALADRIUS BIOSCIENCES, INC. (until Sep 15, 2022); NeoStem, Inc. (until Jun 5, 2015); PHASE III MEDICAL INC/DE (until Sep 1, 2006); CORNICHE GROUP INC /DE (until Aug 14, 2003)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.